SEB Asset Management AB Purchases Shares of 27,012 The Clorox Company $CLX

Posted by on Jul 24th, 2026

SEB Asset Management AB acquired a new position in shares of The Clorox Company (NYSE:CLX – Free Report) in the first quarter, Holdings Channel.com reports. The institutional investor acquired 27,012 shares of the company’s stock, valued at approximately $2,799,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Haverford Trust Co boosted its position in shares of Clorox by 2.8% during the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after buying an additional 84 shares during the last quarter. Field & Main Bank lifted its stake in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after acquiring an additional 100 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after acquiring an additional 100 shares in the last quarter. Kestra Private Wealth Services LLC boosted its holdings in Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock worth $617,000 after acquiring an additional 104 shares during the last quarter. Finally, Johnson Financial Group Inc. boosted its holdings in Clorox by 3.1% during the 3rd quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock worth $451,000 after acquiring an additional 109 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.63% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CLX. Barclays increased their target price on shares of Clorox from $85.00 to $86.00 and gave the company an “underweight” rating in a report on Tuesday. Evercore restated an “underperform” rating and set a $98.00 price target on shares of Clorox in a report on Thursday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. UBS Group increased their price objective on shares of Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a research note on Thursday, July 16th. Finally, Morgan Stanley dropped their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus target price of $102.80.

Check Out Our Latest Research Report on CLX

Clorox Price Performance

Shares of NYSE:CLX opened at $93.81 on Friday. The company has a market capitalization of $11.34 billion, a P/E ratio of 15.23 and a beta of 0.54. The company’s 50-day moving average is $95.00 and its 200 day moving average is $103.89. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.00.

Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter last year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts forecast that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.